GenMark Diagnostics to Participate in the Canaccord Genuity Growth Conference

CARLSBAD, Calif., July 25, 2019 (GLOBE NEWSWIRE) — GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the company plans to participate in the upcoming Canaccord Genuity Growth Conference in Boston, MA.